article thumbnail

HP&M’s Larry Houck A Panelist at FDLI’s Cannabis Regulation Conference

FDA Law Blog: Biosimilars

Hyman, Phelps & McNamara Director Larry Houck will participate as a panelist focusing on this timely topic at the Food and Drug Law Institute’s (“FDLI’s”) Legal and Practical Issues in Cannabis Regulation Conference next month. The conference, held in Washington, D.C., April 4th and 5th, is an in-person and virtual event.

article thumbnail

Analysis Chemical Thank You The 103 regulations the EPA is currently working on

Agency IQ

The 103 regulations the EPA is currently working on On July 5, 2024, the EPA published its Spring 2024 Unified Agenda, which reveals what regulations the agency is planning on releasing by the end of the year and beyond.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Children in Chile saw 73% fewer TV ads for unhealthy foods and drinks following trailblazing marketing restrictions

SCIENMAG: Medicine & Health

The country’s multi-phased regulations, which began in 2016, have led to a 73% drop in children’s exposure to TV ads for regulated foods and drinks (those […]

article thumbnail

African Parliamentarians rally to boost life-saving laws, regulations on road safety

The Pharma Data

African Parliamentarians rally to boost life-saving laws, regulations on road safety Parliamentarians, policy-makers and experts from 10 African countries met today to strengthen laws and actions to curb the scourge of road crash deaths. Source link: [link]

article thumbnail

Analysis Life Sciences Thank You Landscape analysis: A look at the regulation of decentralized trials and what’s coming soon

Agency IQ

Landscape analysis: A look at the regulation of decentralized trials and what’s coming soon In the past few years, regulators and researchers have shown increased interest in leveraging decentralized trial methods – especially following the pandemic. In early 2023, AgencyIQ conducted a landscape analysis of DCT policy in the U.S.

article thumbnail

Looking beyond traditional oncogenic pathways to break cancer resistance

Drug Target Review

BRAF and downstream mitogen-activated extracellular signal-regulated kinase (MEK) inhibitors are combined to treat BRAF-mutated melanoma, for example. Inhibiting KDM5A, a regulator of cell proliferation, poses another interesting approach. 2016 Jul 1 [cited 2024 Sep 4];12(7):531–8. Available from: [link] 10.Vinogradova

article thumbnail

Malaria unravelled: decoding the parasite’s gene expression control

Drug Target Review

Researchers from Tokyo Tech’s World Research Hub Initiative conducted a study to investigate the regulation of gene expression in the apicoplast of the malaria parasite Plasmodium falciparum. How is melatonin, the circadian signalling hormone, related to the regulation of gene expression in the apicoplast?

RNA 98